Endogenous IL-17 contributes to reduced tumor growth and metastasis
Top Cited Papers
Open Access
- 9 July 2009
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 114 (2) , 357-359
- https://doi.org/10.1182/blood-2008-09-177360
Abstract
It has been reported that ectopically expressed interleukin-17 (IL-17) in tumor cells suppresses tumor progression through enhanced antitumor immunitKeywords
This publication has 21 references indexed in Scilit:
- Ozone exposure in a mouse model induces airway hyperreactivity that requires the presence of natural killer T cells and IL-17The Journal of Experimental Medicine, 2008
- Cutting Edge: Opposite Effects of IL-1 and IL-2 on the Regulation of IL-17+ T Cell Pool IL-1 Subverts IL-2-Mediated SuppressionThe Journal of Immunology, 2007
- Cutting Edge: Th17 and Regulatory T Cell Dynamics and the Regulation by IL-2 in the Tumor MicroenvironmentThe Journal of Immunology, 2007
- A crucial role for interleukin (IL)-1 in the induction of IL-17–producing T cells that mediate autoimmune encephalomyelitisThe Journal of Experimental Medicine, 2006
- IL-17 Plays an Important Role in the Development of Experimental Autoimmune EncephalomyelitisThe Journal of Immunology, 2006
- Th17: An Effector CD4 T Cell Lineage with Regulatory T Cell TiesImmunity, 2006
- What does it mean to be just 17?Nature, 2006
- Diversification of T-helper-cell lineages: finding the family root of IL-17-producing cellsNature Reviews Immunology, 2006
- IL-17 Enhances the Net Angiogenic Activity and In Vivo Growth of Human Non-Small Cell Lung Cancer in SCID Mice through Promoting CXCR-2-Dependent AngiogenesisThe Journal of Immunology, 2005
- Interleukin 17–producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineagesNature Immunology, 2005